Helicobacter pylori and skin autoimmune diseases

World Journal of Gastroenterology

Volumn 20, Issue 6, 2014, Pages 1510-1516

  Magen, Eli ^a   Delgado, Jorge Shmuel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Autoimmune; Helicobacter pylori; Infection; Skin

Indexed keywords

ALOPECIA; ANAPHYLACTOID PURPURA; ARTICLE; AUTOIMMUNE SKIN DISEASE; BEHCET DISEASE; BULLOUS SKIN DISEASE; CYTOKINE PRODUCTION; DERMATOMYOSITIS; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; PATHOGEN CLEARANCE; PSORIASIS; SCLERODERMA; SKIN LUPUS ERYTHEMATOSUS; URTICARIA; VITILIGO; ALOPECIA AREATA; AUTOIMMUNE DISEASE; COMPLICATION; HELICOBACTER INFECTION; MICROBIOLOGY; SKIN; SKIN DISEASE; SYSTEMIC SCLEROSIS; VASCULITIS;

ALOPECIA AREATA; AUTOIMMUNE DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PSORIASIS; PURPURA, SCHOENLEIN-HENOCH; SCLERODERMA, SYSTEMIC; SKIN; SKIN DISEASES; URTICARIA; VASCULITIS;

EID: 84893799729     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i6.1510     Document Type: Article

References (79)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315 [PMID: 6145023 DOI: 10.1016/ S0140-6736(84)91816-6]
2. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010; 362: 1597-1604 [PMID: 20427808 DOI: 10.1056/NEJMcp1001110]
3. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, Falush D, Stamer C, Prugnolle F, van der Merwe SW, Yamaoka Y, Graham DY, Perez-Trallero E, Wadstrom T, Suerbaum S, Achtman M. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007; 445: 915-918 [PMID: 17287725 DOI: 10.1038/nature05562]
4. Ram M, Barzilai O, Shapira Y, Anaya JM, Tincani A, Stojanovich L, Bombardieri S, Bizzaro N, Kivity S, Agmon Levin N, Shoenfeld Y. Helicobacter pylori serology in autoimmune diseases-fact or fiction? Clin Chem Lab Med 2013; 51: 1075-1082 [PMID: 23079514 DOI: 10.1515/cclm-2012-0477]
5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789 [PMID: 11556297 DOI: 10.1056/NEJMoa001999]
6. Kobayashi M, Lee H, Nakayama J, Fukuda M. Carbohydratedependent defense mechanisms against Helicobacter pylori infection. Curr Drug Metab 2009; 10: 29-40 [PMID: 19149511 DOI: 10.2174/138920009787048428]
7. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186 [PMID: 12374879 DOI: 10.1056/NEJMra020542]
8. Harris PR, Smythies LE, Smith PD, Dubois A. Inflammatory cytokine mRNA expression during early and persistent Helicobacter pylori infection in nonhuman primates. J Infect Dis 2000; 181: 783-786 [PMID: 10669377 DOI: 10.1086/315257]
9. Kim SY, Lee YC, Kim HK, Blaser MJ. Helicobacter pylori CagA transfection of gastric epithelial cells induces interleukin-8. Cell Microbiol 2006; 8: 97-106 [PMID: 16367869 DOI: 10.1111/j.1462-5822.2005.00603.x]
10. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176 [PMID: 1682595 DOI: 10.1016/0140-6736(91)92035-Z]
11. Robinson K, Kenefeck R, Pidgeon EL, Shakib S, Patel S, Polson RJ, Zaitoun AM, Atherton JC. Helicobacter pyloriinduced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 2008; 57: 1375-1385 [PMID: 18467372 DOI: 10.1136/gut.2007.137539]
12. Sayi A, Kohler E, Toller IM, Flavell RA, Müller W, Roers A, Müller A. TLR-2-activated B cells suppress Helicobacterinduced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J Immunol 2011; 186: 878-890 [PMID: 21149607 DOI: 10.4049/jimmunol.1002269]
13. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Müller A. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011; 121: 3088-3093 [PMID: 21737881 DOI: 10.1172/JCI45041]
14. Maldonado RA, von Andrian UH. How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol 2010; 108: 111-165 [PMID: 21056730 DOI: 10.1016/B978-0-12-380995-7.0 0004-5]
15. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005; 6: 1219-1227 [PMID: 16244650 DOI: 10.1038/ni1265]
16. Hitzler I, Oertli M, Becher B, Agger EM, Müller A. Dendritic cells prevent rather than promote immunity conferred by a helicobacter vaccine using a mycobacterial adjuvant. Gastroenterology 2011; 141: 186-196, 196.e1 [PMID: 21569773 DOI: 10.1053/j.gastro.2011.04.009]
17. Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS, Takeuchi T, Owyang SY, Luther J. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 2010; 138: 1046-1054 [PMID: 19931266 DOI: 10.1053/j.gastro.2009.11.043]
18. Oertli M, Sundquist M, Hitzler I, Engler DB, Arnold IC, Reuter S, Maxeiner J, Hansson M, Taube C, Quiding-Järbrink M, Müller A. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest 2012; 122: 1082-1096 [PMID: 22307326 DOI: 10.1172/JCI61029]
19. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009; 7: 887-894 [PMID: 19898491 DOI: 10.1038/nrmicro2245]
20. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B, Maurer M. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426 [PMID: 19772512]
21. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau AM, Grattan CE, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-1443 [PMID: 19772513 DOI: 10.1111/j.1398-9995.2009.02178.x]
22. Tong LJ, Balakrishnan G, Kochan JP, Kinét JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997; 99: 461-465 [PMID: 9111489 DOI: 10.1016/S0091-6749(97)70071-X]
23. Hizal M, Tüzün B, Wolf R, Tüzün Y. The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int J Dermatol 2000; 39: 443-445 [PMID: 10944089 DOI: 10.1046/j.1365-4362.2000.00979.x]
24. Magen E, Mishal J, Schlesinger M, Scharf S. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. Helicobacter 2007; 12: 567-571 [PMID: 17760727 DOI: 10.1111/ j.1523-5378.2007.00522.x]
25. Galadari IH, Sheriff MO. The role of Helicobacter pylori in urticaria and atopic dermatitis. Skinmed 2006; 5: 172-176 [PMID: 16855407 DOI: 10.1111/j.1540-9740.2006.04646.x]
26. Başkan EB, Türker T, Gülten M, Tunali S. Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria. Int J Dermatol 2005; 44: 993-995 [PMID: 16409261 DOI: 10.1111/ j.1365-4632.2005.02280.x]
27. Fukuda S, Shimoyama T, Umegaki N, Mikami T, Nakano H, Munakata A. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol 2004; 39: 827-830 [PMID: 15565400 DOI: 10.1007/s00535-004-1397-7]
28. Di Campli C, Gasbarrini A, Nucera E, Franceschi F, Ojetti V, Sanz Torre E, Schiavino D, Pola P, Patriarca G, Gasbarrini G. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 1998; 43: 1226-1229 [PMID: 9635612 DOI: 10.1023/A:1018851623109]
29. Bakos N, Fekete B, Prohászka Z, Füst G, Kalabay L. High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pylori-associated lipoprotein in chronic urticaria. Allergy 2003; 58: 663-667 [PMID: 12823128 DOI: 10.1034/ j.1398-9995.2003.00200.x]
30. Mini R, Figura N, D'Ambrosio C, Braconi D, Bernardini G, Di Simplicio F, Lenzi C, Nuti R, Trabalzini L, Martelli P, Bovalini L, Scaloni A, Santucci A. Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. Proteomics 2005; 5: 777-787 [PMID: 15668992 DOI: 10.1002/ pmic.200401094]
31. Giclas PC, Wisniesky J. Autoantibodies to complement components. In: Rose NR, Macario EC, Folds JD, Lane HC, Nakamura RM. Manual of Clinical Laboratory Immunology. Washington DC: ASM Press, 1997: 960-967
32. Tokunaga Y, Shirahase H, Yamamoto E, Gouda Y, Kanaji K, Ohsumi K. Semiquantitative evaluation for diagnosis of Helicobacter pylori infection in relation to histological changes. Am J Gastroenterol 1998; 93: 26-29 [PMID: 9448168 DOI: 10.1111/j.1572-0241.1998.026_c.x]
33. Gala Ortiz G, Cuevas Agustín M, Erias Martínez P, de la Hoz Caballer B, Fernández Ordoñez R, Hinojosa Macías M, Boixeda D, Losada Cosmes E. Chronic urticaria and Helicobacter pylori. Ann Allergy Asthma Immunol 2001; 86: 696-698 [PMID: 11428745 DOI: 10.1016/S1081-1206(10)62301-0]
34. Shiotani A, Okada K, Yanaoka K, Itoh H, Nishioka S, Sakurane M, Matsunaka M. Beneficial effect of Helicobacter pylori eradication in dermatologic diseases. Helicobacter 2001; 6: 60-65 [PMID: 11328367 DOI: 10.1046/ j.1523-5378.2001.00009.x]
35. Ojetti V, Armuzzi A, De Luca A, Nucera E, Franceschi F, Candelli M, Zannoni GF, Danese S, Di Caro S, Vastola M, Schiavino D, Gasbarrini G, Patriarca G, Pola P, Gasbarrini A. Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria. Int Arch Allergy Immunol 2001; 125: 66-72 [PMID: 11385290 DOI: 10.1159/000053798]
36. Kasperska-Zajac A, Sztylc J, Machura E, Jop G. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy 2011; 41: 1386-1391 [PMID: 21645137 DOI: 10.1111/j.1365-2222.2011.03789.x]
37. Gaig P, García-Ortega P, Enrique E, Papo M, Quer JC, Richard C. Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebocontrolled double blind study. Allergol Immunopathol (Madr) 2002; 30: 255-258 [PMID: 12396958 DOI: 10.1016/ S0301-0546(02)79133-7]
38. Akashi R, Ishiguro N, Shimizu S, Kawashima M. Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol 2011; 38: 761-766 [PMID: 21352335 DOI: 10.1111/ j.1346-8138.2010.01106.x]
39. Magen E, Mishal J. Possible benefit from treatment of Helicobacter pylori in antihistamine-resistant chronic urticaria. Clin Exp Dermatol 2013; 38: 7-12 [PMID: 23083221 DOI: 10.1111/j.1365-2230.2012.04467.x]
40. Magen E, Schlesinger M, Hadari I. Chronic urticaria can be triggered by eradication of Helicobacter pylori. Helicobacter 2013; 18: 83-87 [PMID: 23067254 DOI: 10.1111/hel.12010]
41. Shakouri A, Compalati E, Lang DM, Khan DA. Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system. Curr Opin Allergy Clin Immunol 2010; 10: 362-369 [PMID: 20610979 DOI: 10.1097/ACI.0b013e32833c79d7]
42. Schön MP, Boehncke WH. Psoriasis. N Engl J Med 2005; 352: 1899-1912 [PMID: 15872205 DOI: 10.1056/NEJMra041320]
43. Onsun N, Arda Ulusal H, Su O, Beycan I, Biyik Ozkaya D, Senocak M. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. Eur J Dermatol 2012; 22: 117-120 [PMID: 22063790 DOI: 10.1684/ ejd.2011.1579]
44. Sáez-Rodríguez M, Noda-Cabrera A, García-Bustínduy M, Guimerá-Martín-Neda F, Dorta-Alom S, Escoda-García M, Fagundo-González E, Sánchez-González R, Rodríguez-García F, García-Montelongo R. Palmoplantar pustulosis associated with gastric Helicobacter pylori infection. Clin Exp Dermatol 2002; 27: 720 [PMID: 12472559 DOI: 10.1046/ j.1365-2230.2002.01102_6.x]
45. Qayoom S, Ahmad QM. Psoriasis and Helicobacter pylori. Indian J Dermatol Venereol Leprol 2003; 69: 133-134 [PMID: 17642857]
46. Ali M, Whitehead M. Clearance of chronic psoriasis after eradication therapy for Helicobacter pylori infection. J Eur Acad Dermatol Venereol 2008; 22: 753-754 [PMID: 18005018 DOI: 10.1111/j.1468-3083.2007.02452.x]
47. Martin Hübner A, Tenbaum SP. Complete remission of palmoplantar psoriasis through Helicobacter pylori eradication: a case report. Clin Exp Dermatol 2008; 33: 339-340 [PMID: 18201263 DOI: 10.1111/j.1365-2230.2007.02634.x]
48. Radić M, Kaliterna DM, Radić J. Helicobacter pylori infection and systemic sclerosis-is there a link? Joint Bone Spine 2011; 78: 337-340 [PMID: 21145276 DOI: 10.1016/ j.jbspin.2010.10.005]
49. Reinauer S, Goerz G, Ruzicka T, Susanto F, Humfeld S, Reinauer H. Helicobacter pylori in patients with systemic sclerosis: detection with the 13C-urea breath test and eradication. Acta Derm Venereol 1994; 74: 361-363 [PMID: 7817672]
50. Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, Tamaki T, Tamaki K. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol 1998; 25: 650-653 [PMID: 9558164]
51. Danese S, Zoli A, Cremonini F, Gasbarrini A. High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. J Rheumatol 2000; 27: 1568-1569 [PMID: 10852299]
52. Radić M, Martinović Kaliterna D, Bonacin D, Morović Vergles J, Radić J. Correlation between Helicobacter pylori infection and systemic sclerosis activity. Rheumatology (Oxford) 2010; 49: 1784-1785 [PMID: 20498013 DOI: 10.1093/rheumatology/keq137]
53. Gasbarrini A, Massari I, Serricchio M, Tondi P, De Luca A, Franceschi F, Ojetti V, Dal Lago A, Flore R, Santoliquido A, Gasbarrini G, Pola P. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon. Dig Dis Sci 1998; 43: 1641-1645 [PMID: 9724144 DOI: 10.1023/A:018842527111]
54. Csiki Z, Gál I, Sebesi J, Szegedi G. Raynaud syndrome and eradication of Helicobacter pylori. Orv Hetil 2000; 141: 2827-2829 [PMID: 11202119]
55. Kalabay L, Fekete B, Czirják L, Horváth L, Daha MR, Veres A, Fónyad G, Horváth A, Viczián A, Singh M, Hoffer I, Füst G, Romics L, Prohászka Z. Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 2002; 7: 250-256 [PMID: 12165033 DOI: 10.1046/ j.1523-5378.2002.00092.x]
56. Dudda-Subramanya R, Alexis AF, Siu K, Sinha AA. Alopecia areata: genetic complexity underlies clinical heterogeneity. Eur J Dermatol 2007; 17: 367-374 [PMID: 17673378]
57. Tosti A, Pretolani S, Figura N, Polini M, Cameli N, Cariani G, Miglio F, Bonvicini F, Baldini L, Gnucci E, Lucente P, Gasbarrini G. Helicobacter pylori and skin diseases. Gastroenterol Int 1997; 10: 37-39
58. Rigopoulos D, Katsambas A, Karalexis A, Papatheodorou G, Rokkas T. No increased prevalence of Helicobacter pylori in patients with alopecia areata. J Am Acad Dermatol 2002; 46: 141 [PMID: 11756964 DOI: 10.1067/mjd.2002.117255]
59. Abdel Hafez HZ, Mahran AM, Hofny EM, Attallah DA, Sayed DS, Rashed H. Alopecia areata is not associated with Helicobacter pylori. Indian J Dermatol 2009; 54: 17-19 [PMID: 20049262 DOI: 10.4103/0019-5154.48979]
60. Campuzano-Maya G. Cure of alopecia areata after eradication of Helicobacter pylori: a new association? World J Gastroenterol 2011; 17: 3165-3170 [PMID: 21912461 DOI: 10.3748/wjg.v17.i26.3165]
61. Pay S, Simşek I, Erdem H, Dinç A. Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 2007; 27: 417-424 [PMID: 17171346 DOI: 10.1007/s00296-006-0281-6]
62. Kulaber A, Tugal-Tutkun I, Yentür SP, Akman-Demir G, Kaneko F, Gül A, Saruhan-Direskeneli G. Pro-inflammatory cellular immune response in Behçet's disease. Rheumatol Int 2007; 27: 1113-1118 [PMID: 17549482 DOI: 10.1007/ s00296-007-0367-9]
63. Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Gonçalves O, Valente J. Behçet's disease--a contemporary review. J Autoimmun 2009; 32: 178-188 [PMID: 19324519 DOI: 10.1016/j.jaut.2009.02.011]
64. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000; 102: 833-839 [PMID: 10952949 DOI: 10.1161/01.CIR.102.8.833]
65. Avci O, Ellidokuz E, Simşek I, Büyükgebiz B, Güneş AT. Helicobacter pylori and Behçet's disease. Dermatology 1999; 199: 140-143 [PMID: 10559580 DOI: 10.1159/000018221]
66. Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S. H pylori infection in patients with Behcet's disease. World J Gastroenterol 2007; 13: 2983-2985 [PMID: 17589951]
67. Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch-Schönlein): current state of knowledge. Curr Opin Rheumatol 2013; 25: 171-178 [PMID: 23318735 DOI: 10.1097/BOR.0b013e32835d8e2a]
68. Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, García-Fuentes M, González-Gay MA. Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 1997; 40: 859-864 [PMID: 9153547 DOI: 10.1002/art.1780400513]
69. Reinauer S, Megahed M, Goerz G, Ruzicka T, Borchard F, Susanto F, Reinauer H. Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol 1995; 33: 876-879 [PMID: 7593800 DOI: 10.1016/019 0-9622(95)90426-3]
70. Machet L, Vaillant L, Machet MC, Büchler M, Lorette G. Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. Dermatology 1997; 194: 86 [PMID: 9031803 DOI: 10.1159/000246068]
71. Mozrzymas R, d'Amore ES, Montini G, Guariso G. Schönlein-Henoch vasculitis and chronic Helicobacter pylori associated gastritis and duodenal ulcer: a case report. Pediatr Med Chir 1997; 19: 467-468 [PMID: 9595588]
72. Cecchi R, Torelli E. Schönlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection. J Dermatol 1998; 25: 482-484 [PMID: 9714985]
73. Hoshino C. Adult onset Schönlein-Henoch purpura associated with Helicobacter pylori infection. Intern Med 2009; 48: 847-851 [PMID: 19443983 DOI: 10.2169/internalmedicine.48.1718]
74. Shin JI, Koh H, Lee JS. Henoch-Schönlein purpura associated with helicobacter pylori infection: the pathogenic roles of IgA, C3, and cryoglobulins? Pediatr Dermatol 2009; 26: 768-769 [PMID: 20199470 DOI: 10.1111/j.1525-1470.2009.01039.x]
75. Ljubojevic S, Lipozenčić J. Autoimmune bullous diseases associations. Clin Dermatol 2012; 30: 17-33 [PMID: 22137223 DOI: 10.1016/j.clindermatol.2011.03.006]
76. Tampoia M, Giavarina D, Di Giorgio C, Bizzaro N. Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis. Autoimmun Rev 2012; 12: 121-126 [PMID: 22781589 DOI: 10.1016/j.autrev.2012.07.006]
77. Lo Schiavo A, Ruocco E, Brancaccio G, Caccavale S, Ruocco V, Wolf R. Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies. Clin Dermatol 2013; 31: 391-399 [PMID: 23806156 DOI: 10.1016/j.clindermatol.20 13.01.006]
78. Matsuo A, Tanaka R, Shiotani A, Haruma K, Ishii N, Hashimoto T, Fujimoto W. Remission of sublamina densa-type linear IgA bullous dermatosis after Helicobacter pylori eradication. Clin Exp Dermatol 2009; 34: e988-e989 [PMID: 19832860 DOI: 10.1111/j.1365-2230.2009.03631.x]
79. Sagi L, Baum S, Agmon-Levin N, Sherer Y, Katz BS, Barzilai O, Ram M, Bizzaro N, SanMarco M, Trau H, Shoenfeld Y. Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature. Autoimmun Rev 2011; 10: 527-535 [PMID: 21527361 DOI: 10.1016/ j.autrev.2011.04.003]